share_log

Elevation Oncology Q4 EPS $(0.19) Beats $(0.23) Estimate; Cash, Cash Equivalents And Marketable Securities And Approximately $17M In Net Proceeds Raised Under Its ATM Facility Is Expected To Provide Cash Runway Into Fourth Quarter Of 2025

Moomoo 24/7 ·  Mar 6 07:36

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.23) by 17.39 percent. This is a 76.83 percent increase over losses of $(0.82) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment